Next Article in Journal
Comorbidities and Quality of Life among Breast Cancer Survivors: A Prospective Study
Previous Article in Journal
Do Health Professionals Need Additional Competencies for Stratified Cancer Prevention Based on Genetic Risk Profiling?
Open AccessReview

Market Access Advancements and Challenges in “Drug-Companion Diagnostic Test” Co-Development in Europe

1
Phamax Analytics Resources Pvt. Ltd. #19, KMJ Ascend 1st Cross, 17th C Main 5th Block, Koramangala Bangalore 560 095, India
2
Unicorn, POB 91, Zhytomyr 10020, Ukraine
*
Author to whom correspondence should be addressed.
Academic Editor: Stephen B. Liggett
J. Pers. Med. 2015, 5(2), 213-228; https://doi.org/10.3390/jpm5020213
Received: 27 March 2015 / Revised: 25 May 2015 / Accepted: 26 May 2015 / Published: 12 June 2015
The pharma ecosphere is witnessing a measured transformation from the one-size-fits-all or blockbuster model of drugs to more informed and tailored personalized treatments that facilitate higher safety and efficacy for a relevant sub-population. However, with several breakthroughs still in a nascent stage, market access becomes a crucial factor for commercial success, especially when it comes to co-creating value for pertinent stakeholders. This article highlights diverse issues from stakeholder perspectives in Europe, specifically the ones which require immediate resolution. Furthermore, the article also discusses case studies articulating potential solutions for the issues discussed. View Full-Text
Keywords: Stratified medicine; companion diagnostics; market access; cost-effectiveness; value addition Stratified medicine; companion diagnostics; market access; cost-effectiveness; value addition
Show Figures

Figure 1

MDPI and ACS Style

Akhmetov, I.; Ramaswamy, R.; Akhmetov, I.; Thimmaraju, P.K. Market Access Advancements and Challenges in “Drug-Companion Diagnostic Test” Co-Development in Europe. J. Pers. Med. 2015, 5, 213-228.

Show more citation formats Show less citations formats

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Back to TopTop